Integrating Cardiovascular Risk Assessment into Metabolic Dysfunction–associated Steatotic Liver Disease Drug Development

Journal of Clinical and Experimental Hepatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles